Valuation: Avantor, Inc.

Market Cap 7.02B 6.15B 5.67B 5.31B 9.96B 662B 10.17B 68.18B 26.38B 327B 26.36B 25.78B 1,135B P/E 2026 *
28.6x
P/E 2027 * 23.8x
Enterprise Value 10.03B 8.79B 8.11B 7.59B 14.23B 946B 14.53B 97.44B 37.7B 468B 37.67B 36.84B 1,622B EV / Sales 2026 *
1.54x
EV / Sales 2027 * 1.41x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 50 24/06/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-2.93% - - 7.02B
+0.94%+6.46%-29.96%-12.54% 164B
+1.48%+2.07%-5.86%-6.23% 104B
-0.29%+5.26%-4.44%+50.82% 55.67B
0.00%-5.19%+49.08%+51.42% 52.92B
+3.00%+8.29%-8.74%-39.80% 42.96B
+2.91%+8.15% - - 32.87B
+2.17%-3.22%-18.75%-44.52% 27.07B
+1.24%+6.98%+60.30%-4.97% 24.79B
+2.41%+6.45%-9.68%-0.56% 21.02B
Average +1.47%+3.81%+3.99%-0.80% 58.32B
Weighted average by Cap. +1.24%+3.98%-5.61%-0.41%

Financials

2026 *2027 *
Net sales 6.5B 5.7B 5.25B 4.92B 9.23B 613B 9.42B 63.16B 24.44B 303B 24.42B 23.88B 1,051B 6.64B 5.82B 5.37B 5.02B 9.42B 626B 9.62B 64.49B 24.96B 310B 24.93B 24.39B 1,073B
Net income 244M 214M 197M 185M 346M 23B 353M 2.37B 917M 11.37B 916M 896M 39.42B 289M 253M 234M 219M 410M 27.26B 419M 2.81B 1.09B 13.47B 1.09B 1.06B 46.72B
Net Debt 3.01B 2.64B 2.43B 2.28B 4.27B 284B 4.36B 29.26B 11.32B 140B 11.31B 11.06B 487B 2.36B 2.07B 1.91B 1.79B 3.35B 223B 3.42B 22.95B 8.88B 110B 8.87B 8.68B 382B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Trader
Investor
Global
Quality
ESG MSCI
-